{"transactions":[{"id":759951,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":43461,"kind":"person","name":"Grossman Jerrold B","position":1,"cik":"0001542519","reported_name":"Grossman Jerrold B","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-28T20:05:25.000Z","date":"2026-05-27","kind":"purchase","planned":false,"acquired":true,"shares":6400,"price":7.91,"value":50624.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents an open market purchase in a single transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes, as of the transaction date, (i) 10,690 RSUs granted on February 9, 2026, half of which will vest on August 9, 2026, and the other half of which will vest on February 9, 2027, subject to the Reporting Person's continued service as of each such vesting date; and (ii) 509,594 shares of common stock owned by the Reporting Person."}],"balance_after":520284,"source":{"system":"sec-edgar","filing":"0001140361-26-023127","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036126023127/form4.xml","form_type":"4"}},{"id":778757,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":43461,"kind":"person","name":"Grossman Jerrold B","position":1,"cik":"0001542519","reported_name":"Grossman Jerrold B","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-14T11:00:16.000Z","date":"2026-05-12","kind":"purchase","planned":false,"acquired":true,"shares":12500,"price":8.01,"value":100125.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents an open market purchase in a single transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes, as of the transaction date, (i) 10,690 RSUs granted on February 9, 2026, half of which will vest on August 9, 2026, and the other half of which will vest on February 9, 2027, subject to the Reporting Person's continued service as of each such vesting date; and (ii) 503,194 shares of common stock owned by the Reporting Person."}],"balance_after":513884,"source":{"system":"sec-edgar","filing":"0001140361-26-021150","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036126021150/form4.xml","form_type":"4"}},{"id":782099,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":43461,"kind":"person","name":"Grossman Jerrold B","position":1,"cik":"0001542519","reported_name":"Grossman Jerrold B","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-12T21:22:51.000Z","date":"2026-05-11","kind":"purchase","planned":false,"acquired":true,"shares":12500,"price":8.01,"value":100125.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents an open market purchase in a single transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes, as of the transaction date, (i) 10,690 RSUs granted on February 9, 2026, which will fully vest on February 9, 2027, subject to the Reporting Person's continued service as of such vesting date; and (ii) 490,694 shares of common stock owned by the reporting person."}],"balance_after":501384,"source":{"system":"sec-edgar","filing":"0001140361-26-020855","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036126020855/form4.xml","form_type":"4"}},{"id":909609,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":43461,"kind":"person","name":"Grossman Jerrold B","position":1,"cik":"0001542519","reported_name":"Grossman Jerrold B","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-12T02:00:22.000Z","date":"2026-02-09","kind":"grant","planned":false,"acquired":true,"shares":17730,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"These options vest in twelve equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant."}],"balance_after":17730,"derivative":{"exercise_price":16.37,"expiration_date":"2036-02-09","underlying":"Common Stock","underlying_shares":17730},"source":{"system":"sec-edgar","filing":"0001140361-26-004892","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036126004892/form4.xml","form_type":"4"}},{"id":909608,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":43461,"kind":"person","name":"Grossman Jerrold B","position":1,"cik":"0001542519","reported_name":"Grossman Jerrold B","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-02-12T02:00:22.000Z","date":"2026-02-09","kind":"grant","planned":false,"acquired":true,"shares":10690,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the Reporting Person's continued service as of the applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes, as of the transaction date, (i) 10,690 RSUs granted on February 9, 2026, which will fully vest on February 9, 2027, subject to the Reporting Person's continued service as of such vesting date; (ii) 5,445 RSUs out of 10,889 RSUs granted on February 19, 2025, which will vest fully on February 19, 2026, subject to the Reporting Person's continued service as of such vesting date; and (iii) 472,749 shares of common stock owned by the reporting person."}],"balance_after":488884,"source":{"system":"sec-edgar","filing":"0001140361-26-004892","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036126004892/form4.xml","form_type":"4"}},{"id":1116062,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":43461,"kind":"person","name":"Grossman Jerrold B","position":1,"cik":"0001542519","reported_name":"Grossman Jerrold B","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-06-11T01:00:32.000Z","date":"2025-06-09","kind":"exercise","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"These options were granted on February 14, 2017 and vested in twenty-four equal monthly installments, becoming fully vested on February 14, 2019."}],"balance_after":0,"derivative":{"exercise_price":5,"expiration_date":"2027-02-14","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001140361-25-022113","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036125022113/form4.xml","form_type":"4"}},{"id":1116061,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":43461,"kind":"person","name":"Grossman Jerrold B","position":1,"cik":"0001542519","reported_name":"Grossman Jerrold B","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-11T01:00:32.000Z","date":"2025-06-09","kind":"sale","planned":false,"acquired":false,"shares":10000,"price":21.31,"value":213100.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.29 to $21.35. The reporting person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes, as of the transaction date, (i) 10,889 restricted stock units granted on February 19, 2025, which will vest in full on February 19, 2026, subject to the Reporting Person's continued service as of the applicable vesting date; and (ii) 467,305 shares of common stock owned by the reporting person."}],"balance_after":478194,"source":{"system":"sec-edgar","filing":"0001140361-25-022113","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036125022113/form4.xml","form_type":"4"}},{"id":1116060,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":43461,"kind":"person","name":"Grossman Jerrold B","position":1,"cik":"0001542519","reported_name":"Grossman Jerrold B","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-11T01:00:32.000Z","date":"2025-06-09","kind":"exercise","planned":false,"acquired":true,"shares":10000,"price":5,"value":50000.0,"ownership":{"direct":true},"balance_after":488194,"source":{"system":"sec-edgar","filing":"0001140361-25-022113","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036125022113/form4.xml","form_type":"4"}},{"id":1252443,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":43461,"kind":"person","name":"Grossman Jerrold B","position":1,"cik":"0001542519","reported_name":"Grossman Jerrold B","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-22T02:05:28.000Z","date":"2025-02-19","kind":"grant","planned":false,"acquired":true,"shares":16279,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The options vest in 12 equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant."}],"balance_after":16279,"derivative":{"exercise_price":16.07,"expiration_date":"2035-02-19","underlying":"Common Stock","underlying_shares":16279},"source":{"system":"sec-edgar","filing":"0001140361-25-005538","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036125005538/form4.xml","form_type":"4"}},{"id":1252442,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":43461,"kind":"person","name":"Grossman Jerrold B","position":1,"cik":"0001542519","reported_name":"Grossman Jerrold B","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-02-22T02:05:28.000Z","date":"2025-02-19","kind":"grant","planned":false,"acquired":true,"shares":10889,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the Reporting Person's continued service as of the applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes, as of the transaction date, (i) 10,889 RSUs granted on February 19, 2025 and reported on this Form 4, subject to vesting as set forth in footnote (1); (ii) 12,020 restricted stock units granted on February 26, 2024, which will vest in full on February 26, 2025, subject to the Reporting Person's continued service as of the applicable vesting date; and (iii) 455,285 shares of common stock owned by the Reporting Person."}],"balance_after":478194,"source":{"system":"sec-edgar","filing":"0001140361-25-005538","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036125005538/form4.xml","form_type":"4"}},{"id":1418842,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":43461,"kind":"person","name":"Grossman Jerrold B","position":1,"cik":"0001542519","reported_name":"Grossman Jerrold B","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-08-31T01:02:08.000Z","date":"2024-08-29","kind":"exercise","planned":false,"acquired":false,"shares":9000,"price":10.8,"value":97200.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F10","text":"The Reporting Person is exercising these options due, in part, to their near-term expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"These options were granted on January 30, 2015 and vested in twenty-four equal monthly installments, becoming fully vested on January 30, 2017."}],"balance_after":0,"derivative":{"exercise_price":10.8,"expiration_date":"2025-01-30","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001140361-24-039821","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036124039821/form4.xml","form_type":"4"}},{"id":1418841,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":43461,"kind":"person","name":"Grossman Jerrold B","position":1,"cik":"0001542519","reported_name":"Grossman Jerrold B","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-08-31T01:02:08.000Z","date":"2024-08-29","kind":"exercise","planned":false,"acquired":false,"shares":9000,"price":5.96,"value":53640.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F10","text":"The Reporting Person is exercising these options due, in part, to their near-term expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"These options were granted on January 28, 2016 and vested in twenty-four equal monthly installments, becoming fully vested on January 28, 2018."}],"balance_after":0,"derivative":{"exercise_price":5.96,"expiration_date":"2026-01-28","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001140361-24-039821","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036124039821/form4.xml","form_type":"4"}},{"id":1418840,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":43461,"kind":"person","name":"Grossman Jerrold B","position":1,"cik":"0001542519","reported_name":"Grossman Jerrold B","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-08-31T01:02:08.000Z","date":"2024-08-29","kind":"exercise","planned":false,"acquired":false,"shares":118861,"price":3.66,"value":435031.26,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"These options were granted on June 6, 2017 and vested in twenty-four equal monthly installments, becoming fully vested on June 6, 2019."}],"balance_after":0,"derivative":{"exercise_price":3.66,"expiration_date":"2027-06-06","underlying":"Common Stock","underlying_shares":118861},"source":{"system":"sec-edgar","filing":"0001140361-24-039821","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036124039821/form4.xml","form_type":"4"}},{"id":1418839,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":43461,"kind":"person","name":"Grossman Jerrold B","position":1,"cik":"0001542519","reported_name":"Grossman Jerrold B","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-08-31T01:02:08.000Z","date":"2024-08-29","kind":"sale","planned":false,"acquired":false,"shares":136861,"price":17.2725,"value":2363931.6225,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $17.17 to $17.595. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes, as of the transaction date, (i) 12,020 restricted stock units granted on February 26, 2024, which will vest in full on February 26, 2025, subject to the Reporting Person's continued service as of the applicable vesting date; and (ii) 455,285 shares of common stock owned by the reporting person."}],"balance_after":467305,"source":{"system":"sec-edgar","filing":"0001140361-24-039821","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036124039821/form4.xml","form_type":"4"}},{"id":1418838,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":43461,"kind":"person","name":"Grossman Jerrold B","position":1,"cik":"0001542519","reported_name":"Grossman Jerrold B","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-08-31T01:02:08.000Z","date":"2024-08-29","kind":"exercise","planned":false,"acquired":true,"shares":9000,"price":10.8,"value":97200.0,"ownership":{"direct":true},"balance_after":604166,"source":{"system":"sec-edgar","filing":"0001140361-24-039821","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036124039821/form4.xml","form_type":"4"}},{"id":1418837,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":43461,"kind":"person","name":"Grossman Jerrold B","position":1,"cik":"0001542519","reported_name":"Grossman Jerrold B","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-08-31T01:02:08.000Z","date":"2024-08-29","kind":"exercise","planned":false,"acquired":true,"shares":9000,"price":5.96,"value":53640.0,"ownership":{"direct":true},"balance_after":595166,"source":{"system":"sec-edgar","filing":"0001140361-24-039821","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036124039821/form4.xml","form_type":"4"}},{"id":1418836,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":43461,"kind":"person","name":"Grossman Jerrold B","position":1,"cik":"0001542519","reported_name":"Grossman Jerrold B","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-08-31T01:02:08.000Z","date":"2024-08-29","kind":"exercise","planned":false,"acquired":true,"shares":118861,"price":3.66,"value":435031.26,"ownership":{"direct":true},"balance_after":586166,"source":{"system":"sec-edgar","filing":"0001140361-24-039821","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036124039821/form4.xml","form_type":"4"}},{"id":1611849,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":43461,"kind":"person","name":"Grossman Jerrold B","position":1,"cik":"0001542519","reported_name":"Grossman Jerrold B","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2024-02-29T02:00:46.000Z","date":"2024-02-26","kind":"grant","planned":false,"acquired":true,"shares":37541,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The options vest in 12 equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant."}],"balance_after":37541,"derivative":{"exercise_price":5.4,"expiration_date":"2034-02-26","underlying":"Common Stock","underlying_shares":37541},"source":{"system":"sec-edgar","filing":"0001140361-24-010241","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036124010241/form4.xml","form_type":"4"}},{"id":1611848,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":43461,"kind":"person","name":"Grossman Jerrold B","position":1,"cik":"0001542519","reported_name":"Grossman Jerrold B","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-02-29T02:00:46.000Z","date":"2024-02-26","kind":"grant","planned":false,"acquired":true,"shares":24040,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the reporting person's continued service as of the applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes, as of the transaction date, (i) 24,040 RSUs granted on February 26, 2024 and reported on this Form 4, subject to vesting as set forth in footnote (1); (ii) 25,815 RSUs granted on March 6, 2023, which will vest in full on March 6, 2024; and (iii) 417,450 shares of common stock owned by the reporting person."}],"balance_after":467305,"source":{"system":"sec-edgar","filing":"0001140361-24-010241","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036124010241/form4.xml","form_type":"4"}},{"id":1792853,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":43461,"kind":"person","name":"Grossman Jerrold B","position":1,"cik":"0001542519","reported_name":"Grossman Jerrold B","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-08-30T20:58:14.000Z","date":"2023-08-30","kind":"purchase","planned":false,"acquired":true,"shares":130000,"price":3.7088,"value":482144.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average price of purchases on August 30, 2023. The shares were purchased in multiple transactions ranging from $3.70 to $3.71, inclusive."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes, as of the transaction date, (i) 25,815 RSUs granted on March 6, 2023 that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the reporting person's continued service as of the applicable vesting date; and (ii) 417,450 shares of common stock owned by the reporting person."}],"balance_after":443265,"source":{"system":"sec-edgar","filing":"0001140361-23-041848","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036123041848/form4.xml","form_type":"4"}},{"id":1962763,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":43461,"kind":"person","name":"Grossman Jerrold B","position":1,"cik":"0001542519","reported_name":"Grossman Jerrold B","relationship":{"director":true}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-03-09T02:30:46.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":51630,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The options vest in 12 equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant."}],"balance_after":51630,"derivative":{"exercise_price":3.35,"expiration_date":"2033-03-06","underlying":"Common Stock","underlying_shares":51630},"source":{"system":"sec-edgar","filing":"0001140361-23-010772","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036123010772/form4.xml","form_type":"4"}},{"id":1962762,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":43461,"kind":"person","name":"Grossman Jerrold B","position":1,"cik":"0001542519","reported_name":"Grossman Jerrold B","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-03-09T02:30:46.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":25815,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the reporting person's continued service as of the applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes, as of the transaction date, (i) 25,815 RSUs granted on March 6, 2023 and reported on this Form 4, subject to vesting as set forth in footnote (1); (ii) 13,293 RSUs granted on March 7, 2022, which will vest in full on March 7, 2023; and (iii) 274,157 shares of common stock owned by the reporting person."}],"balance_after":313265,"source":{"system":"sec-edgar","filing":"0001140361-23-010772","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036123010772/form4.xml","form_type":"4"}},{"id":2341309,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":43461,"kind":"person","name":"Grossman Jerrold B","position":1,"cik":"0001542519","reported_name":"Grossman Jerrold B","relationship":{"director":true}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-03-09T22:58:37.000Z","date":"2022-03-07","kind":"grant","acquired":true,"shares":53172,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The options vest in 12 equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant."}],"balance_after":53172,"derivative":{"exercise_price":1.67,"expiration_date":"2032-03-07","underlying":"Common Stock","underlying_shares":53172},"source":{"system":"sec-edgar","filing":"0001140361-22-008670","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036122008670/form4.xml","form_type":"4"}},{"id":2341308,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":43461,"kind":"person","name":"Grossman Jerrold B","position":1,"cik":"0001542519","reported_name":"Grossman Jerrold B","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-03-09T22:58:37.000Z","date":"2022-03-07","kind":"grant","acquired":true,"shares":26586,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the reporting person's continued service as of the applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (i) 26,586 RSUs granted on March 7, 2022 and reported on this Form 4, subject to vesting as set forth in footnote (1); and (ii) 260,864 shares of common stock owned by the reporting person."}],"balance_after":287450,"source":{"system":"sec-edgar","filing":"0001140361-22-008670","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036122008670/form4.xml","form_type":"4"}},{"id":2534409,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":43461,"kind":"person","name":"Grossman Jerrold B","position":1,"cik":"0001542519","reported_name":"Grossman Jerrold B","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-10-26T11:00:47.000Z","date":"2021-10-25","kind":"purchase","acquired":true,"shares":100000,"price":1,"value":100000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a purchase from the underwriters in the October 2021 public offering of the issuer."}],"balance_after":260864,"source":{"system":"sec-edgar","filing":"0001140361-21-035381","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036121035381/form4.xml","form_type":"4"}},{"id":2825627,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":43461,"kind":"person","name":"Grossman Jerrold B","position":1,"cik":"0001542519","reported_name":"Grossman Jerrold B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-03-02T02:03:26.000Z","date":"2021-02-25","kind":"grant","acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in twelve equal monthly installments, becoming fully vested on February 25, 2022."}],"balance_after":55000,"derivative":{"exercise_price":2.35,"expiration_date":"2031-02-25","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001193805-21-000295","document":"e620330_4-jgrossman.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000119380521000295/e620330_4-jgrossman.xml","form_type":"4"}},{"id":3033041,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":43461,"kind":"person","name":"Grossman Jerrold B","position":1,"cik":"0001542519","reported_name":"Grossman Jerrold B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-11T12:00:18.000Z","date":"2020-09-10","kind":"purchase","acquired":true,"shares":5000,"price":2.22,"value":11100.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 3,750 RSUs granted on February 28, 2020 which remain unvested as of the date hereof and will become fully vested on February 28, 2021, subject to the reporting person's continued service as of the applicable vesting date, and will be settled into common stock upon vesting."}],"balance_after":160864,"source":{"system":"sec-edgar","filing":"0001193805-20-001135","document":"e619926_4-jgrossman.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000119380520001135/e619926_4-jgrossman.xml","form_type":"4"}},{"id":3047444,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":43461,"kind":"person","name":"Grossman Jerrold B","position":1,"cik":"0001542519","reported_name":"Grossman Jerrold B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-25T12:00:37.000Z","date":"2020-08-21","kind":"purchase","acquired":true,"shares":300,"price":2.62,"value":786.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 7,500 RSUs granted on February 28, 2020, which will vest in two equal installments, on the six- and 12-month anniversaries of the grant, becoming fully vested on the one-year anniversary of the grant, subject to the reporting person's continued service as of the applicable vesting date, and will be settled into common stock upon vesting."}],"balance_after":155864,"source":{"system":"sec-edgar","filing":"0001193805-20-001069","document":"e619888_4-jgrossman.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000119380520001069/e619888_4-jgrossman.xml","form_type":"4"}},{"id":3047443,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":43461,"kind":"person","name":"Grossman Jerrold B","position":1,"cik":"0001542519","reported_name":"Grossman Jerrold B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-25T12:00:37.000Z","date":"2020-08-21","kind":"purchase","acquired":true,"shares":5000,"price":2.56,"value":12800.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 7,500 RSUs granted on February 28, 2020, which will vest in two equal installments, on the six- and 12-month anniversaries of the grant, becoming fully vested on the one-year anniversary of the grant, subject to the reporting person's continued service as of the applicable vesting date, and will be settled into common stock upon vesting."}],"balance_after":155564,"source":{"system":"sec-edgar","filing":"0001193805-20-001069","document":"e619888_4-jgrossman.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000119380520001069/e619888_4-jgrossman.xml","form_type":"4"}},{"id":3058403,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":43461,"kind":"person","name":"Grossman Jerrold B","position":1,"cik":"0001542519","reported_name":"Grossman Jerrold B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-13T12:01:49.000Z","date":"2020-08-12","kind":"purchase","acquired":true,"shares":5000,"price":2.895,"value":14475.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 7,500 RSUs granted on February 28, 2020, which will vest in two equal installments, on the six- and 12-month anniversaries of the grant, becoming fully vested on the one-year anniversary of the grant, subject to the reporting person's continued service as of the applicable vesting date, and will be settled into common stock upon vesting."}],"balance_after":150564,"source":{"system":"sec-edgar","filing":"0001193805-20-001023","document":"e619872_4-jgrossman.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000119380520001023/e619872_4-jgrossman.xml","form_type":"4"}},{"id":3058402,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":43461,"kind":"person","name":"Grossman Jerrold B","position":1,"cik":"0001542519","reported_name":"Grossman Jerrold B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-13T12:01:49.000Z","date":"2020-08-12","kind":"purchase","acquired":true,"shares":5000,"price":2.89,"value":14450.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 7,500 RSUs granted on February 28, 2020, which will vest in two equal installments, on the six- and 12-month anniversaries of the grant, becoming fully vested on the one-year anniversary of the grant, subject to the reporting person's continued service as of the applicable vesting date, and will be settled into common stock upon vesting."}],"balance_after":145564,"source":{"system":"sec-edgar","filing":"0001193805-20-001023","document":"e619872_4-jgrossman.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000119380520001023/e619872_4-jgrossman.xml","form_type":"4"}},{"id":3058401,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":43461,"kind":"person","name":"Grossman Jerrold B","position":1,"cik":"0001542519","reported_name":"Grossman Jerrold B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-13T12:01:49.000Z","date":"2020-08-12","kind":"purchase","acquired":true,"shares":200,"price":2.87,"value":574.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 7,500 RSUs granted on February 28, 2020, which will vest in two equal installments, on the six- and 12-month anniversaries of the grant, becoming fully vested on the one-year anniversary of the grant, subject to the reporting person's continued service as of the applicable vesting date, and will be settled into common stock upon vesting."}],"balance_after":140564,"source":{"system":"sec-edgar","filing":"0001193805-20-001023","document":"e619872_4-jgrossman.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000119380520001023/e619872_4-jgrossman.xml","form_type":"4"}},{"id":3165063,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":43461,"kind":"person","name":"Grossman Jerrold B","position":1,"cik":"0001542519","reported_name":"Grossman Jerrold B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-01T21:12:01.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). Subsequent to the filing of the initial Form 4 by the Reporting Person on March 3, 2020, the Board of Directors of the Issuer corrected the vesting schedule of the RSUs. The RSUs will vest in two equal installments, on the six- and 12-month anniversaries of the grant, becoming fully vested on the one-year anniversary of the grant, subject to the reporting person's continued service as of the applicable vesting date, and will be settled into common stock upon vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (i) 7,500 RSUs granted on February 28, 2020 and reported on this Form 4, subject to vesting as set forth in footnote (1) and will be settled into common stock upon vesting; and (ii) 132,864 shares of common stock owned by the reporting person."}],"balance_after":140364,"source":{"system":"sec-edgar","filing":"0001193805-20-000552","document":"e619598_4a-jgrossman.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000119380520000552/e619598_4a-jgrossman.xml","form_type":"4/A","original_submission_date":"2020-03-03"}},{"id":3231180,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":43461,"kind":"person","name":"Grossman Jerrold B","position":1,"cik":"0001542519","reported_name":"Grossman Jerrold B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-03-04T00:09:36.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option vests in 12 equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant."}],"balance_after":15000,"derivative":{"exercise_price":2.915,"expiration_date":"2030-02-28","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001193805-20-000288","document":"e619422_4-jgrossman.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000119380520000288/e619422_4-jgrossman.xml","form_type":"4"}},{"id":3231179,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":43461,"kind":"person","name":"Grossman Jerrold B","position":1,"cik":"0001542519","reported_name":"Grossman Jerrold B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-04T00:09:36.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"), which will vest in 12 equal monthly installments, becoming fully vested on the one-year anniversary of the grant, subject to the reporting person's continued service as of the applicable vesting date, and will be settled into common stock upon vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (i) 7,500 RSUs granted on February 28, 2020 and reported on this Form 4, subject to vesting as set forth in footnote (1) and will be settled into common stock upon vesting; and (ii) 132,864 shares of common stock owned by the reporting person."}],"balance_after":140364,"source":{"system":"sec-edgar","filing":"0001193805-20-000288","document":"e619422_4-jgrossman.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000119380520000288/e619422_4-jgrossman.xml","form_type":"4"}},{"id":3279386,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":43461,"kind":"person","name":"Grossman Jerrold B","position":1,"cik":"0001542519","reported_name":"Grossman Jerrold B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-11T15:15:17.000Z","date":"2020-02-11","kind":"purchase","acquired":true,"shares":22857,"price":3.5,"value":79999.5,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a purchase from the underwriters in the Issuer's public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are owned by Brookwood LLC (\"Brookwood\"). The reporting person is the managing member of Brookwood."}],"balance_after":22857,"source":{"system":"sec-edgar","filing":"0001193805-20-000131","document":"e619334_4-jgrossman.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000119380520000131/e619334_4-jgrossman.xml","form_type":"4"}},{"id":3279385,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":43461,"kind":"person","name":"Grossman Jerrold B","position":1,"cik":"0001542519","reported_name":"Grossman Jerrold B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-11T15:15:17.000Z","date":"2020-02-11","kind":"purchase","acquired":true,"shares":22857,"price":3.5,"value":79999.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a purchase from the underwriters in the Issuer's public offering."}],"balance_after":132864,"source":{"system":"sec-edgar","filing":"0001193805-20-000131","document":"e619334_4-jgrossman.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000119380520000131/e619334_4-jgrossman.xml","form_type":"4"}},{"id":3516542,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":43461,"kind":"person","name":"Grossman Jerrold B","position":1,"cik":"0001542519","reported_name":"Grossman Jerrold B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-21T11:14:05.000Z","date":"2019-05-17","kind":"purchase","acquired":true,"shares":12000,"price":4,"value":48000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a purchase from the underwriters in the Issuer's public offering."}],"balance_after":110007,"source":{"system":"sec-edgar","filing":"0001193805-19-000524","document":"e618483_4-jgrossman.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000119380519000524/e618483_4-jgrossman.xml","form_type":"4"}},{"id":3592459,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":43461,"kind":"person","name":"Grossman Jerrold B","position":1,"cik":"0001542519","reported_name":"Grossman Jerrold B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-03-15T21:01:28.000Z","date":"2019-03-13","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in twelve equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The option terminates on the earlier of (i) March 13, 2029 and (ii) the one-year anniversary of the reporting person's ceasing to serve as a director of the Issuer."}],"balance_after":30000,"derivative":{"exercise_price":3.89,"expiration_date":"2029-03-13","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001193805-19-000295","document":"e618304_4-jgrossman.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000119380519000295/e618304_4-jgrossman.xml","form_type":"4"}},{"id":3883850,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":43461,"kind":"person","name":"Grossman Jerrold B","position":1,"cik":"0001542519","reported_name":"Grossman Jerrold B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-25T21:00:19.000Z","date":"2018-06-22","kind":"grant","acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in twenty-four equal monthly installments, becoming fully vested on the two year anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The option terminates on the earlier of (i) June 22, 2028 and (ii) the one year anniversary of the reporting person's ceasing to serve as a director of the Issuer."}],"balance_after":17500,"derivative":{"exercise_price":4.91,"expiration_date":"2028-06-22","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001193805-18-000901","document":"e618126_4-jgrossman.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000119380518000901/e618126_4-jgrossman.xml","form_type":"4"}},{"id":3898049,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":43461,"kind":"person","name":"Grossman Jerrold B","position":1,"cik":"0001542519","reported_name":"Grossman Jerrold B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-11T11:10:02.000Z","date":"2018-06-08","kind":"purchase","acquired":true,"shares":31381,"price":4.78,"value":150001.18,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a purchase from the underwriters in the Issuer's public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are owned by the Jerrold Grossman 2012 Nevada SLAT, of which Dr. Grossman serves as investment trustee."}],"balance_after":31381,"source":{"system":"sec-edgar","filing":"0001193805-18-000821","document":"e618087_4-jgrossman.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000119380518000821/e618087_4-jgrossman.xml","form_type":"4"}},{"id":3898048,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":43461,"kind":"person","name":"Grossman Jerrold B","position":1,"cik":"0001542519","reported_name":"Grossman Jerrold B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-11T11:10:02.000Z","date":"2018-06-08","kind":"purchase","acquired":true,"shares":20921,"price":4.78,"value":100002.38,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a purchase from the underwriters in the Issuer's public offering."}],"balance_after":98007,"source":{"system":"sec-edgar","filing":"0001193805-18-000821","document":"e618087_4-jgrossman.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000119380518000821/e618087_4-jgrossman.xml","form_type":"4"}},{"id":4256339,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":43461,"kind":"person","name":"Grossman Jerrold B","position":1,"cik":"0001542519","reported_name":"Grossman Jerrold B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-07-17T21:13:25.000Z","date":"2017-07-13","kind":"exercise","acquired":false,"shares":48185,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option vested in equal monthly installments over the four (4) year period following July 16, 2007."}],"balance_after":0,"derivative":{"exercise_price":2.68,"expiration_date":"2017-07-16","underlying":"Common Stock","underlying_shares":48185},"source":{"system":"sec-edgar","filing":"0001193805-17-001299","document":"e616385_4-jgrossman.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000119380517001299/e616385_4-jgrossman.xml","form_type":"4"}},{"id":4256338,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":43461,"kind":"person","name":"Grossman Jerrold B","position":1,"cik":"0001542519","reported_name":"Grossman Jerrold B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-07-17T21:13:25.000Z","date":"2017-07-13","kind":"tax_withholding","acquired":false,"shares":39132,"price":3.3,"value":129135.6,"ownership":{"direct":true},"balance_after":77086,"source":{"system":"sec-edgar","filing":"0001193805-17-001299","document":"e616385_4-jgrossman.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000119380517001299/e616385_4-jgrossman.xml","form_type":"4"}},{"id":4256337,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":43461,"kind":"person","name":"Grossman Jerrold B","position":1,"cik":"0001542519","reported_name":"Grossman Jerrold B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-07-17T21:13:25.000Z","date":"2017-07-13","kind":"exercise","acquired":true,"shares":48185,"price":2.68,"value":129135.8,"ownership":{"direct":true},"balance_after":116218,"source":{"system":"sec-edgar","filing":"0001193805-17-001299","document":"e616385_4-jgrossman.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000119380517001299/e616385_4-jgrossman.xml","form_type":"4"}},{"id":4288061,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":43461,"kind":"person","name":"Grossman Jerrold B","position":1,"cik":"0001542519","reported_name":"Grossman Jerrold B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-06-08T22:02:36.000Z","date":"2017-06-06","kind":"grant","acquired":true,"shares":118861,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in twenty-four equal monthly installments, becoming fully vested on the two year anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The option terminates on the earlier of (i) June 6, 2027 and (ii) the one year anniversary of the reporting person's ceasing to serve as a director of the Issuer."}],"balance_after":118861,"derivative":{"exercise_price":3.66,"expiration_date":"2027-06-06","underlying":"Common Stock","underlying_shares":118861},"source":{"system":"sec-edgar","filing":"0001193805-17-001057","document":"e616264_4-jgrossman.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000119380517001057/e616264_4-jgrossman.xml","form_type":"4"}},{"id":4442118,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":43461,"kind":"person","name":"Grossman Jerrold B","position":1,"cik":"0001542519","reported_name":"Grossman Jerrold B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-02-17T01:12:30.000Z","date":"2017-02-14","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in twenty-four equal monthly installments, becoming fully vested on the two year anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The option terminates on the earlier of (i) February 14, 2027 and (ii) the one year anniversary of the reporting person's ceasing to serve as a director of the Issuer."}],"balance_after":10000,"derivative":{"exercise_price":5,"expiration_date":"2027-02-14","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001193805-17-000277","document":"e615797_4-jgrossman.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000119380517000277/e615797_4-jgrossman.xml","form_type":"4"}}]}